Metabolic and Cardiovascular Impact of CD36 Deficiency in African Americans
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 12/31/2016 |
| Start Date: | August 2013 |
| End Date: | December 2016 |
CD36, a protein that facilitates tissue uptake of fat, as a common link between blood fat
concentrations and metabolic disease states such as diabetes mellitus. Genetic variants in
the CD36 gene are more common in African Americans compared to Whites and it may confer
protection against metabolic diseases by altering the amount of fat in the blood.
The purpose of this study is to compare the levels of fat in the blood and to assess
endothelial dysfunction among carriers versus non-carriers of the coding SNP, rs3211938 of
the CD36 gene after a high fat meal challenge
concentrations and metabolic disease states such as diabetes mellitus. Genetic variants in
the CD36 gene are more common in African Americans compared to Whites and it may confer
protection against metabolic diseases by altering the amount of fat in the blood.
The purpose of this study is to compare the levels of fat in the blood and to assess
endothelial dysfunction among carriers versus non-carriers of the coding SNP, rs3211938 of
the CD36 gene after a high fat meal challenge
Inclusion Criteria:
- African American men and women age 18-65 years of age
- BMI 25-45 kg/m2
Exclusion Criteria:
- Diabetes
- Pregnancy
- Use of nicotinic acid for dyslipidemia
- History of nutrient malabsorption
- Clinically significant hepatic or renal disease, OR serum creatinine or liver
function tests > 2times upper limits of normal
- Symptomatic acute or chronic gallbladder disease
- Any underlying or acute disease requiring regular medication which could in the
principal investigator's opinion possibly pose a threat to the subject or make
implementation of the protocol difficult
- Mental conditions rendering the subject unable to understand the nature, scope and
possible consequences of the study
- Patient unwilling or unable to give informed consent
We found this trial at
1
site
2201 West End Ave
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-7311
Principal Investigator: Cyndya A Shibao, MD
Phone: 615-689-1033
Vanderbilt University Vanderbilt offers undergraduate programs in the liberal arts and sciences, engineering, music, education...
Click here to add this to my saved trials
